VcMMAE-Deruxtecan

VcMMAE-Deruxtecan

• UNSPSC Description: VcMMAE-Deruxtecan is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule MMAE (HY-15162) (Microtubule inhibitor) and Exatecan (HY-13631) (DNA topoisomerase I inhibitor). VcMMAE-Deruxtecan can be used for ADC synthesis.
• Target Antigen: Drug-Linker Conjugates for ADC; Microtubule/Tubulin; Topoisomerase
• Type: ADC Related
• Related Pathways: Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage;Cytoskeleton
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/vcmmae-deruxtecan.html
• Smiles: O=C(C=CC1=O)N1CCCCCC(NC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=O)C(NC2=CC=C(COC(N(C)[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N3[C@@]([C@H](OC)[C@@H](C)C(N[C@H](C)[C@@H](O)C4=CC=CC=C4)=O)([H])CCC3)=O)C)=O)=O)=O)C=C2)=O)=O)C(NCC(N[C@@H](CC5=CC=CC=C5)C(NCC(NCOCC(N[C@@H]6C7=C8C(C(N9C8)=CC([C@](O)(C(OC%10)=O)CC)=C%10C9=O)=NC%11=CC(F)=C(C)C(CC6)=C%117)=O)=O)=O)=O)=O)=O
• Molecular Weight: 2155.46
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported